The Fenland Study is investigating the interaction between environmental and genetic factors in determining obesity, type 2 diabetes, and related metabolic disorders. These conditions are a considerable public health concern, but their causes and factors that predict who will be affected by them are not completely understood.
The Fenland Study is unique in the level of detail it collects about the health and lifestyle of participants, and the objective measurement techniques used in the screening.
Phase 1 of the Fenland study was completed in 2015, and Phase 2 in 2020. We are now conducting Phase 3.
